Stay updated on PF-06801591 Dose Escalation in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PF-06801591 Dose Escalation in Solid Tumors Clinical Trial page.

Latest updates to the PF-06801591 Dose Escalation in Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedSite revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedRevision: v3.4.2 was added and the previous entry v3.4.1 was removed. A government funding status notice that was previously displayed has been deleted. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check38 days agoChange DetectedA government-funding status notice appears on the page and the site version has been updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check45 days agoChange DetectedA glossary toggle was added, and non-substantive label/version text changes were made (e.g., 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0' with capitalization tweaks like 'No FEAR Act Data'). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3; this is a minor page version update that does not change the content or study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check80 days agoChange DetectedAdded numerous study locations across the US (California, Kentucky, Nevada, New York, North Carolina, Tennessee) and international sites (Pazardzhik; Johor, Kuala Lumpur, Pahang, Sarawak; Leningradskaya Oblast, Sankt-Peterburg; Gyeonggi-do), removed several existing location blocks including US state locations and the HHS Vulnerability Disclosure, and updated the page to revision v3.3.3.SummaryDifference1.0%

Stay in the know with updates to PF-06801591 Dose Escalation in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-06801591 Dose Escalation in Solid Tumors Clinical Trial page.